Identification of potential target genes of honokiol in overcoming breast cancer resistance to tamoxifen
Background: Honokiol (HON) inhibits epidermal growth factor receptor (EGFR) signaling and increases the activity of erlotinib, an EGFR inhibitor, in human head and neck cancers. In this study, using a bioinformatics approach and in vitro experiments, we assessed the target genes of HON against breas...
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
Frontier
2022
|
| Θέματα: | |
| Διαθέσιμο Online: | https://repository.ugm.ac.id/278741/1/Hermawan-2_FA.pdf |